Long-lasting enhancement of rapid eye movement sleep and pontogeniculooccipital waves by vasoactive intestinal peptide microinjection into the amygdala temporal lobe

Division de Investigaciones en Neurociencias, Departamento de Cronobiología, Instituto Nacional de Psiquiatria Ramón de la Fuente, Tlalpan, Mexico, D.F.
Sleep (Impact Factor: 4.59). 06/2003; 26(3):259-64.
Source: PubMed


The effect of a vasoactive intestinal peptide (VIP) microinjection into the amygdaloid central (CN) and basal nuclei (BN) on sleep organization and on the number and pattern of occurrence of pontogeniculooccipital (PGO) waves was analyzed.
One group of 8 cats was studied in baseline conditions and after the microinjection of two doses of VIP applied into the CN and BN.
Sleep research laboratory. PARTCIPANTS AND INTERVENTIONS: Eight cats were prepared with sleep-recording electrodes and with guide tubes in both amygdalae for saline and VIP microinjections. Neuropeptide doses of 0.10 microg/1 microl (30 microM) and 0.33 microg/1 microl (99.24 microM) were employed.
Once the microinjection was applied, 23-hour polygraphic sleep recordings were performed for 5 consecutive days. Concomitantly the PGO waves were tape-recorded on each day and computationally analyzed. Results show that the 0.10 microg/1 microl microinjection produced no change. Unilateral VIP 0.33 microg/1 microl injection into the CN provoked a significant and lasting increase in the percentage of slow-wave sleep with PGO waves. Bilateral application of VIP increased the percentage of slow-wave sleep with PGO waves and rapid eye movement sleep for 5 days. Bilateral microinjection of the neuropeptide into the BN only enhanced the percentage of slow wave sleep with PGO waves. For both amygdaloid nuclei, we observed that VIP increased the number and modified the PGO wave pattern of occurrence during slow-wave sleep with PGO waves and during rapid eye movement sleep.
The VIP microinjection into both the CN and BN induces increased amounts of rapid eye movement sleep, PGO waves, and slow-wave sleep with PGO waves, having a more robust effect on all of these three variables when applied into the CN.

Download full-text


Available from: Ignacio Ramírez Salado,
  • Source
    • "It is known that the limbic network, including the ventral striatum, hypothalamus, and amygdala show increased activation during laughter and rapid-eye-movement (REM) sleep (Maquet et al 2006). Furthermore, stimulation of the amygdala can increase REM sleep, perhaps via its projections to the laterodorsal nuclei, pedunculopontine tegmental nuclei, and nearby regions (Calvo et al 1996; Simón-Arceo et al 2003). The clinical observation that NC patients have cataplectic attacks when they experience positive emotions led to the hypothesis that abnormal processing of external emotional input through the limbic system, or motor dysregulation induced by emotions, takes place during these episodes. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Based on the clinical observation that patients suffering from narcolepsy with cataplexy (NC) have cataplectic attacks when they experience positive emotions, it is therefore hypothesised that the abnormal processing of external emotional input through the limbic system, or motor dysregulation induced by emotions, takes place during these episodes. To date, imaging studies have failed to reveal consistent brain abnormalities in NC patients. Considering the discrepancies in reported structural or functional abnormalities of the hypothalamus, amygdala, and nucleus accumbens, we used the MRI volumetry to determine the volumes of the amygdala and nucleus accumbens in a group of eleven patients with NC (5 males and 6 females, mean age 41.7 years ± 17.7). This data was compared to an equal number of examinations in healthy volunteers matched for age and gender. We found a decrease in the amygdalar volume of NC patients in both raw (p<0.001) and relative (p<0.01) data sets. The difference in amygdalar volume between healthy volunteers and NC patients was about 17%. In contrast to the amygdala, we did not find any differences in the volumes of nucleus accumbens. In the present MRI volumetric study, we found bilateral gray matter loss in the amygdala only.
    Neuro endocrinology letters 01/2011; 32(5):652-6. · 0.80 Impact Factor
  • Source

    Sleep 10/2004; 27(6):1209-12. · 4.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A variety of medications representing several major drug classes improve cataplexy in patients with narcolepsy. These include aminergic reuptake inhibitors such as venlafaxine and clomipramine as well as sodium oxybate. This review is intended to familiarize readers with the safety and efficacy of these medications, thus enabling clinicians to optimize their management of cataplexy.
    Sleep Medicine Reviews 11/2004; 8(5):355-66. DOI:10.1016/j.smrv.2004.01.004 · 8.51 Impact Factor
Show more